These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 4504181)

  • 21. Definition of cure for Hodgkin's disease.
    Frei E; Gehan EA
    Cancer Res; 1971 Nov; 31(11):1828-33. PubMed ID: 5121689
    [No Abstract]   [Full Text] [Related]  

  • 22. [Confrontation of our therapeutic results in Hodgkin's disease (author's transl)].
    Dienstbier Z; Masopust J; Sámal M; Zámecnik J; Kirschnerová Z; Tschernoster E
    Sb Lek; 1979 Jul; 81(7):208-15. PubMed ID: 482849
    [No Abstract]   [Full Text] [Related]  

  • 23. The cost-effectiveness of high dose chemotherapy in the treatment of relapsed Hodgkin's disease and non-Hodgkin's lymphoma.
    Beard SM; Lorigan PC; Sampson FC
    Br J Cancer; 2000 Jan; 82(1):81-4. PubMed ID: 10638970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.
    Meyer RM; Gospodarowicz MK; Connors JM; Pearcey RG; Bezjak A; Wells WA; Burns BF; Winter JN; Horning SJ; Dar AR; Djurfeldt MS; Ding K; Shepherd LE; ;
    J Clin Oncol; 2005 Jul; 23(21):4634-42. PubMed ID: 15837968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors in pathologic stage III Hodgkin's disease.
    Hoppe RT; Cox RS; Rosenberg SA; Kaplan HS
    Cancer Treat Rep; 1982 Apr; 66(4):743-9. PubMed ID: 7074644
    [No Abstract]   [Full Text] [Related]  

  • 26. [Failures in the treatment of Hodgkin's disease in children].
    Armata J; Borkowski W; Kaczor Z
    Pol Tyg Lek; 1980 Nov; 35(46):1769-71. PubMed ID: 7243639
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prognosis and therapy of Hodgkin's disease].
    Hartmann F; Pfreundschuh M; Diehl V
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():75-9. PubMed ID: 8692124
    [No Abstract]   [Full Text] [Related]  

  • 28. Late effects after therapy of Hodgkin's disease: update 2003/04 on overwhelming post-splenectomy infections and secondary malignancies.
    Schellong G; Riepenhausen M
    Klin Padiatr; 2004; 216(6):364-9. PubMed ID: 15565552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
    Urquhart A; Berg R
    Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Surgical staging of Hodgkin's disease. Considerations after 10 years' experience].
    Saba V; Chan R; Braccioni U
    Minerva Med; 1982 Apr; 73(15):935-8. PubMed ID: 7078791
    [No Abstract]   [Full Text] [Related]  

  • 31. Pediatric Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria.
    Constine LS; Wolkov HB; Yahalom J; Mauch PM; Deming RL; Dosoretz DE; Elman AJ; Hoppe RT; Pistenmaa DA; Prosnitz LR; Chauvenet A; Connors JM; Glick JH; Leibel S
    Radiology; 2000 Jun; 215 Suppl():1225-56. PubMed ID: 11037544
    [No Abstract]   [Full Text] [Related]  

  • 32. Outcome in Hodgkin's disease: a 20-year cohort of patients.
    Ranaghan L; Markey GM; Morris TC
    Ulster Med J; 1998 Nov; 67(2):91-8. PubMed ID: 9885544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical aspects and therapy of stage III Hodgkin's disease (author's transl)].
    Weh HJ; Andrieu JM
    MMW Munch Med Wochenschr; 1980 Jun; 122(25):932-4. PubMed ID: 6772941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [EORTC studies in Hodgkin's disease].
    Somers R; Burgers JM; Hartgrink-Groeneveld CA; Kazem I; Noordijk EM; Qasim MM; Sizoo W; van Unnik JA; Wagener DJ
    Ned Tijdschr Geneeskd; 1982 Apr; 126(14):616-22. PubMed ID: 6804879
    [No Abstract]   [Full Text] [Related]  

  • 35. [Combined radiation and chemotherapy of Hodgkin's disease. (Evaluation of the material of 110 patients for the years 1959-1964)].
    Hoppe D
    Radiobiol Radiother (Berl); 1971; 12(1):45-52. PubMed ID: 5099414
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical study of Hodgkin's disease after 25 years].
    Dienstbier Z; Skala E; Blomannová E
    Cas Lek Cesk; 2004; 143(3):184-6. PubMed ID: 15134038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remodeling the pyramid or remodeling the paradigms concerning rheumatoid arthritis--lessons from Hodgkin's disease and coronary artery disease.
    Pincus T; Callahan LF
    J Rheumatol; 1990 Dec; 17(12):1582-5. PubMed ID: 2084231
    [No Abstract]   [Full Text] [Related]  

  • 38. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
    Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
    Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Is Hodgkin's disease a curable disease?].
    Easson E
    Nouv Rev Fr Hematol; 1966; 6(1):109-11. PubMed ID: 4222287
    [No Abstract]   [Full Text] [Related]  

  • 40. [Results of the treatment of Hodgkin's disease at the Institute of Oncology in Warsaw in the years 1960-1964].
    Nowak G; Pieńkowska F; Wróblowa M
    Nowotwory; 1972; 22(2):127-9. PubMed ID: 5038533
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.